Dextroamphetamine recalls
The FDA has published 11 recalls involving Dextroamphetamine since 2013. The latest was reported on 8 Jul 2026. Most were for potency & assay. Amedra Pharmaceuticals has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls11since 2013
Last 12 months1reported
Class I19% of total
Ongoing2latest 8 Jul 2026
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 1 9%Class II 10 91%Class III 0 0%
Why dextroamphetamine is recalled
Companies
Brands
By year
Ongoing dextroamphetamine recalls
2 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Dextroamphetamine Saccharate recalled by Lannett CompanyDextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine Sulfate | Lannett | Packaging Defects | Nationwide |
| Drug | CLASS II | Xelstrym (dextroamphetamine) transdermal system recalledXelstrym | Noven Pharmaceuticals | Packaging Defects | Nationwide |
All dextroamphetamine recalls, newest first
11 totalShould you stop taking Dextroamphetamine?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.